University Hospitals Cleveland
Cleveland, OH
Dr. McClelland received his artium baccalaureus with honors in biology from Harvard College, and his medical degree from the Columbia University College of Physicians and Surgeons. He is internationally recognized for his 15-year track record of investigating disparities in healthcare access and for his work on radiation-based modalities for treatment of central nervous system disease. He is a member of the NRG Oncology Health Disparities Scientific Core Committee.
Dr. McClelland has won numerous national awards; in addition to being a two-time winner of the Conquer Cancer Foundation Merit Award from the American Society of Clinical Oncology, he has received the Young Oncologist Travel Award from the American Radium Society, the Young Investigator Award from the American Epilepsy Society, the International Epilepsy Symposium Research Award from the Cleveland Clinic, the Cone Pevehouse Award from the American Association of Neurological Surgeons, and the Trainee Research Prize from the Radiological Society of North America. His work has been presented at more than 30 national and international scientific meetings including the American Society for Radiation Oncology, Congress of Neurological Surgeons, Society for Neuro-Oncology, and the International Stereotactic Radiosurgery Society.
Creator of the Radiosurgery Dose Reduction for Brain Metastases on Immunotherapy (RADREMI) clinical trial and the Navigator-Assisted Hypofractionation (NAVAH) breast cancer program, Dr. McClelland has published more than 140 articles (117 first-author publications) in peer-reviewed journals including The Lancet, Lancet Oncology and JAMA Oncology.
Disclosures:
Sunday, September 29, 2024
11:35 AM – 11:43 AM ET